The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs.- myeloma effect

Lignende værker

• WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and donor lymphocyte infusions
  af: Tyler, Eleanor M., et al.
  Udgivet: (2013)
• Cancer/testis antigen 7 expression and immune responses following allogeneic stem cell transplantation for multiple myeloma
  af: Tyler, Eleanor M., et al.
  Udgivet: (2014)
• Fractionated Stem Cell Infusions for Patients with Plasma Cell Myeloma Undergoing Autologous Hematopoietic Cell Transplantation
  af: Landau, Heather, et al.
  Udgivet: (2016)
• Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
  af: Kharfan-Dabaja, Mohamed A., et al.
  Udgivet: (2018)
• Response and toxicity of donor lymphocyte infusions following T cell depleted non-myeloablative allogeneic hematopoietic stem cell transplantation from 3–6/6 HLA matched donors
  af: Rizzieri, David A, et al.
  Udgivet: (2008)